A 22-year-old male was admitted to our hospital after taking 2450 mg of pilsicainide. On admission, the patient was in cardiac arrest, and percutaneous cardiopulmonary support was introduced to maintain his circulation. After three days of intensive care, he was no impaired consciousness and transferred another hospital for psychological problem.